首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到18条相似文献,搜索用时 109 毫秒
1.
马传桃 《生理学报》1994,46(4):394-398
本实验复制清醒羊低氧性肺动脉高压模型,观察肺动脉高压发生发展及逆转过程中血浆内源性血小板活化因子(plateletactivatingfactor,PAF)的动态变化。结果表明:(1)低氧4d引起低氧血症,导致肺血管收缩,形成肺动脉高压;停止低氧后可逆转;(2)开始低氧,血中内源性PAF升高,但低氧时间延长血浆中PAF却不随肺动脉压升高相应增加;(3)停止低氧,血浆PAF不随肺动脉高压的逆转而相应降低。上述结果表明血浆PAF的变化与肺动脉高压无关。提示血中内源性PAF不介导清醒羊低氧性肺血管收缩导致的肺动脉高压。  相似文献   

2.
用共聚焦激光扫描显微镜观察经Fluo-3/AM负荷的慢性低氧性肺动脉高压(HPH)大鼠原代培养的肺动脉平滑肌细胞(PASMC)的形态与内游离Ca2+浓度的动态变化。结果表明:原代培养的(HPH)大鼠的PASMC与正常大鼠相比,①细胞内游离Ca2+浓度增加,但其收缩性减弱;②随培养日数增加,咖啡因(Cafein)所致的细胞内储钙池-肌浆网的Ca2+释放作用逐渐减弱,直至消失;③血管紧张素Ⅱ(AT-Ⅱ)升高细胞内钙作用明显增强;④部分呈大红色细胞对多种缩血管物质敏感性增强。结果提示,HPH大鼠的PASMC的内钙明显增加,其调节机制处于紊乱状态。  相似文献   

3.
本工作采用分离培养家兔肺内小动脉平滑肌细胞(PASMCs),观察了外源性血小板活化因子(plateletactivatingfactor,PAF)、BN52021(PAF受体拮抗剂)、吲哚美辛、维拉帕米对PASMCs产生血栓素A_2(TxA_2)、前列环素(PGI_2)及对细胞膜Ca~(2+)-ATPase活力的影响。结果表明:(1)基础状态下PASMCs存在花生四烯酸(AA)代谢。(2)外源性PAF通过受体后途径激活环加氧酶促进AA代谢致TXA_2及PGI-2增加,TXA_2/PGI_2比值无明显变化。(3)外源性PAF能直接抑制Ca~(2+)-ATPase活力。(4)维拉帕米可逆转PAF抑制PASMCs膜Ca~(2+)-ATPase活力的效应。  相似文献   

4.
目的:探讨使用外源性肺表面活性物质(PS)治疗能否减轻烟雾吸入所致肺组织细胞损害。方法:Wistar大鼠随机分为5组:Ⅰ组,正常对照;Ⅱ组,烟雾吸入;Ⅲ组,烟雾+PS+机械通气(MV);Ⅳ组,烟雾+盐水+MV;Ⅴ组,烟雾+MV,伤后5min经气管导管注入PS(100mg/kg)或等量盐水,MV4h,观察24h,检测动脉血气、肺水量、支气管肺泡灌洗液(BALF)中白细胞分类计数及乳酸脱氢酶(LDH)、血管紧张素转换酶(ACE)和碱性磷酸酶(AKP)活性、胎盘型碱性磷酸酶(PLAP)含量、肺泡壁纤维成分含量及病理检查等。结果:Ⅱ组伤后发生呼吸衰竭、肺水肿及肺部急性炎症反应,BALF中LDH、AKP、ACE和PLAP水平均明显升高,肺泡壁纤维成分含量显著减少。Ⅲ组血气较Ⅱ组明显改善,但BALF中各酶水平、肺泡壁纤维成分含量及肺部炎症、水肿等无显著减轻。Ⅳ、Ⅴ组治疗无效。结论:烟雾吸入伤早期外源性PS治疗能一定程度改善呼吸功能,但对肺组织细胞损害无明显保护作用,不能减轻继发性炎症反应和急性肺水肿  相似文献   

5.
牛磺酸调节缺氧性肺、脑血管反应的机理研究   总被引:9,自引:0,他引:9  
本实验从磷脂酶A_2(PLA_2)、前列腺素(PGs)、白三烯(LTs)和过氧化脂质(LPO)方面探讨了牛磺酸调节肺、脑血管对急、慢性缺氧反应的机制。急性缺氧时狗出肺与出脑血中LPO增加,PLA,活性有升高趋势,但出脑与出肺(入脑)血相比无显著性差异。出肺与出脑血中LTC_4、TXB_2、6-Keto-PGF_(1a)及TXB_2/6-Keto-PGF_(1a)比值均升高。慢性缺氧大鼠肺、脑组织中PLA_2活性均升高。牛磺酸增加缺氧时6-Keto-PGF_(1a),减弱其它变化。提示牛磺酸对缺氧性肺缩血管反应的调节作用可能与降低缺氧时PLA_2活性,抑制脂质过氧化和LTC_4、TXA_2生成,降低TXA_2/PGI_2比值有关;而牛磺酸减弱缺氧性脑舒血管反应不是直接通过上述变化起作用的。  相似文献   

6.
应用蛋白dotblot技术检测了低氧内皮细胞条件培养液(HECCM)和常氧内皮细胞条件培养液(NECCM)内PDGF相对含量,并利用[3H]-TdR掺入法和流式细胞术观察了HECCM和NECCM及加入特异PDGF抗体对肺动脉平滑肌细胞(PASMC)生长的影响。结果表明,HECCM中的PDGF含量明显高于NECCM;HECCM能明显增强PASMC内DNA合成,促进PASMC从Go/G1期进入S期;当预先加入PDGF-B链抗体时,则会明显地抑制HECCM对PASMC的DNA合成,阻止PASMC从Go/G1期进入S期。结果提示,低氧时PASMC增殖与肺动脉内皮细胞分泌释放PDGF增加有关  相似文献   

7.
本课题观察了低氧及血管紧张素Ⅱ(angiotensinⅡ,AngⅡ)对分离培养家兔肺内小动脉平滑肌细胞(PASM-Cs)膜Ca2+-ATPase活力的影响,同时用钙通道阻断剂维拉帕米(verapamil,VP)进行干预,进一步了解细胞内钙与Ca2+-ATPase活力的关系。结果表明:PASMCs膜Ca2+-ATPase活力对低氧具有短暂的耐受性,随低氧时间延长,Ca2+-ATPase活力呈时间依赖性抑制;低氧、ANGⅡ均能抑制Ca2+-ATPase活力(P<0.01)低氧+AⅡ对Ca2+-ATPase活力的抑制具叠加效应(P<0.05);VP可逆转低氧、AngⅡ、低氧+AngⅡ对Ca2+-ATPase活力的抑制(P<0.01)。结果提示:低氧,ANGⅡ可通过抑制肺血管平滑肌细胞膜Ca2+-ATPase活力而可能削弱肺血管平滑肌舒张功能也可能是低氧性肺动脉高压(HPH)形成的原因之一。  相似文献   

8.
观察了吸入0.004%的一氧化氮(NO)对急、慢性缺氧大鼠血流动力学、缺氧性肺血管收缩反应(HPV)、血气及高铁血红蛋白(MetHb)的影响。结果表明:(1)常氧吸入NO时能明显降低慢性缺氧大鼠肺动脉平均压(Ppa)和肺血管阻力(PVR),但对正常大鼠的Ppa和PVR无明显影响;(2)慢性缺氧大鼠急性缺氧时HPV较正常大鼠弱,吸入NO不但降低两者的急性缺氧肺动脉高压,且完全逆转两者的HPV;(3)吸入NO对急、慢性缺氧大鼠体循环血流动力学、血气及MetHb含量无明显影响。提示吸入NO能选择性降低急、慢性缺氧性肺动脉高压,且逆转HPV。  相似文献   

9.
本研究观察了低氧对大鼠肺组织和血管内皮一氧化氮合酶(NOS)活性及内皮衍生一氧化氮(EDNO)依赖性舒张反应的影响,以及NOS抑制剂(L-NAME)对常氧和低氧大鼠肺组织和血管内皮NOS活性及颈、肺动脉血压(CAPs、mPAP)的作用。结果表明常氧大鼠肺泡内无肌性血管内皮未见NOS活性,其肺血管床对EDNO依赖性舒血管物质BK没有反应,注射L-NAME后大鼠mPAP略有降低,CAPs有所升高。低氧大鼠肺泡内无肌性血管内皮显示NOS活性,对BK的EDNO依赖性舒张反应呈剂量依赖性增大,注射L-NAME使低氧大鼠mPAP显著降低(P<0.01),CAPs显著升高(P<0.05)。提示肺血管EDNO及其合酶在维持正常成年大鼠肺循环低压低阻中的生理作用值得进一步探讨;低氧引起肺血管内皮ecNOS活性增加和EDNO生成增多可能起到限制肺动脉压过度升高的调制作用,也可能对肺血管内皮产生毒性作用,反而促进肺动脉高压的发生和发展。  相似文献   

10.
粉防己碱抑制血管平滑肌细胞增殖及对HSP70和p53表达的影响   总被引:11,自引:0,他引:11  
目的:观察粉防己碱(Tet)对VSMC增殖的作用及对热应激蛋白70kd(HSP70)及其mRNA和抑癌基因p53mRNA的影响。方法:用内皮素建立培养的血管平滑肌细胞增殖模型。采用氚-胸腺嘧啶核苷([3H]TdR)掺入法流式细胞术,Western及Northernblot杂交方法。结果:Tet能逆转内皮素所致的[3H]TdR掺入量增多(P<0.01),阻止血管平滑肌细胞由静止期(G0/G1期)进入DNA合成期(S期)和有丝分裂期(G2/M期),并能逆转内皮素引起的HSP70及mRNA表达增强(P<0.01或P<0.05),p53抑癌基因mRNA表达减弱(P<0.05)。结论:Tet能抑制血管平滑肌细胞增殖,与HSP70及p53的调控有关  相似文献   

11.
磷脂酶A2活力与急性缺氧性肺动脉高压关系的探讨   总被引:4,自引:0,他引:4  
李惠萍  何金兰 《生理学报》1997,49(6):685-689
通过动物实验探讨磷脂酶A2及相关炎性介质在急性缺氧性肺动脉高压形成中的作用。30只SD大鼠随机分为三组;正常对照组,缺氧组及缺氧加地塞米松组。均测定肺动脉压;缺氧30min后,取静脉血肺组织测定PLA2活力,血小板活化因子,前列腺素E2,血栓素B2。  相似文献   

12.
本实验采用急性胃内灌注乙醇的方法,观察了乙醇对狗血流动力学和低氧性肺血管收缩反应(HPV)的影响,同时探讨了白三烯(LTs)在其中的作用。结果表明:①给乙醇(0.5g/kg)后肺血管阻力(PVR)和平均肺动脉压(_(pa))显著升高,用脂氧化酶抑制剂特异性地抑制白三烯的合成后,乙醇引起的PVR和_(pa)升高不显著,表明LTs介导乙醇引起的肺血管收缩反应。②给乙醇后HPV显著增强.急性低氧性肺动脉高压明显加重,用脂氧化酶抑制剂特异性地抑制LTs的合成后.乙醇增强HPV的效应被抑制.表明LTs在乙醇增强HPV的效应中起介导作用。实验结果提示饮酒不利于低氧性肺动脉高压、肺心病和高原性心脏病的防治。  相似文献   

13.
Chronic hypoxia causes pulmonary hypertension and pulmonary vascular remodeling in rats. Because platelet-activating factor (PAF) levels increase in lung lavage fluid and in plasma from chronically hypoxic rats, we examined the effect of two specific, structurally unrelated PAF antagonists, WEB 2170 and BN 50739, on hypoxia-induced pulmonary vascular remodeling. Treatment with either agent reduced hypoxia-induced pulmonary hypertension and right ventricular hypertrophy at 3 wk of hypoxic exposure (simulated altitude 5,100 m) but did not affect cobalt (CoCl2)-induced pulmonary hypertension. The PAF antagonists had no effect on the hematocrit of normoxic or chronically hypoxic rats or CoCl2-treated rats. Hypoxia-induced pulmonary hypertension was associated with an increase in the vessel wall thickness of the muscular arteries and reduction in the number of peripheral arterioles. In WEB 2170-treated rats, these changes were significantly less severe than those observed in untreated chronically hypoxic rats. PAF receptor blockade had no acute hemodynamic effects; i.e., it did not affect pulmonary arterial pressure or cardiac output nor did it affect the magnitude of acute hypoxic pulmonary vasoconstriction in awake normoxic or chronically hypoxic rats. Isolated lungs from chronically hypoxic rats showed a pressor response to the chemotactic tripeptide N-formyl-Met-Leu-Phe (fMLP) and an increase in the number of leukocytes lavaged from the pulmonary circulation. In vivo treatment with WEB 2170 significantly reduced the fMLP-induced pressor response compared with that observed in isolated lungs from untreated chronically hypoxic rats. These results suggest that PAF contributes to the development of chronic pulmonary hypertension induced by chronic hypoxia.(ABSTRACT TRUNCATED AT 250 WORDS)  相似文献   

14.
感觉神经肽与支气管对肺动脉缺氧反应的影响   总被引:1,自引:0,他引:1  
豚鼠离体肺动脉用辣椒素(Capsaicin)耗竭感觉神经肽(SNP)后,缺氧性收缩反应(HPV)显著增高(P<0.01)。套有带完整上皮支气管的肺动脉的HPV显著弱于不套或套有去上皮支气管肺动脉的HPV(P<0.05);支气管与肺动脉同时用Cap处理后,此差异消失;只有外套的支气管先用Cap预处理时,肺动脉HPV仍显著强于溶剂预处理的对照组(P<0.05);套有去上皮支气管的肺动脉缺氧反应显著强于不套支气管的肺动脉。结果提示:肺动脉C-感觉神经所释放的SNP在肺动脉缺氧反应中具调节作用;支气管上皮层可释放舒血管物质调节HPV,此物质与SNP密切相关;支气管还可能释放缩血管物质,介导HPV。  相似文献   

15.
利用右心导管术、光镜、微机辅助测量及透射电镜,综合观察分析了不同时间减压缺氧(5000m高度)对大鼠肺腺泡内动脉(IAA)内皮结构和肌化的影响及与肺动脉高压(PH)的关系。发现:(1)缺氧24h,IAA即有明显肌化;随缺氧时间延长,ф<50μm的外周血管肌化百分率持续增加,与肺动脉压增高及右室肥厚密切相关。揭示IAA肌化为PH形成的重要原因。(2缺氧24h,IAA内皮是显著胞内水肿;缺氧7d,出现内皮下水肿,内皮增生、肥厚;缺氧14d,内皮下水肿严重,内弹力层大部消失,内皮增生、肥厚继续加重;缺氧21及40d,内皮下水肿减轻,但增生、肥厚更重。结合肺动脉压及IAA肌化变化分析,提示因不同缺氧时间段IAA内皮结构不同程度的变化,其参与导致动脉肌化的机制有所不同。  相似文献   

16.
Platelet-activating factor (PAF) administered to the pulmonary circulation in low dose (nanogram) has vasodilatory properties. Therefore, we investigated whether endogenous PAF plays a role in the control of tone in the pulmonary circulation. The PAF receptor antagonists, SRI 63-441 (2.6 X 10(-4) M) and L659,989 (1 X 10(-5) M), were the major investigative tools. In isolated perfused rat lungs, both agents caused a persistent increase in base-line perfusion pressure (Ppa), potentiated angiotensin II (ANG II) vasoconstriction, and potentiated hypoxic vasoconstriction (HPV). This potentiation of ANG II and HPV was found to be independent of circulating blood elements. Vasodilation in the presence of PAF blockade was also impaired. The combination of cyclooxygenase inhibition and PAF receptor blockade had an additive effect on ANG II vasoconstriction but did not cause more potentiation of HPV than achieved with PAF antagonism alone. In vivo, SRI 63-441 (10 mg/kg) caused only a transient increase in base-line Ppa without altering ANG II and hypoxic vasoconstriction. These findings support a vasodilatory role for endogenous PAF in the pulmonary circulation.  相似文献   

17.
用生物测定法观察了川芎嗪对慢性缺氧大鼠肺动脉和主动脉环的舒张效应,并与乙酰胆碱的舒血管作用进行了比较。结果表明:川芎嗪对慢性缺氧大鼠肺动脉和主动脉的舒张作用均与平原组无明显差异。慢性缺氧明显减低了乙酰胆碱诱发的肺动脉内皮依赖性舒张反应,但不影响川芎嗪对肺血管的舒张作用。提示川芎嗪对肺血管的舒张作用不依赖于内皮。川芎嗪对肺动脉的舒张作用明显大于体动脉。这些特性有利于川芎嗪对肺动脉高压的治疗。  相似文献   

18.
Platelet-activating factor (PAF) infusion into sheep, as well as protamine reversal of heparin anticoagulation, causes thromboxane release into plasma, pulmonary hypertension, hypoxemia, and leukopenia. We investigated the possible role of PAF in the heparin-protamine reaction. Intravenous protamine was administered to neutralize heparin anticoagulation in five awake sheep and caused an increase of mean pulmonary arterial pressure from 16.6 +/- 1 (SE) mmHg at base-line to 47 +/- 9 mmHg at 1 min after protamine injection (P < 0.01) because of a 4.5-fold increase of pulmonary vascular resistance. This neutralization reaction induced a 25% reduction of circulating leukocyte count and arterial PO2. Undetectable blood levels of PAF were measured by bioassay and high-performance liquid chromatography during these heparin-protamine reactions. Infusion of BN 52021 (20 mg/kg), a PAF receptor antagonist, before rechallenging the same sheep with heparin and then protamine did not reduce the level of peak pulmonary hypertension or the degree of hypoxemia and leukopenia. We conclude that the leukopenia and thromboxane-mediated pulmonary vasoconstriction occurring after rapid intravascular formation of heparin-protamine complexes in sheep are not due to the release of PAF.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号